A detailed history of Advisor Group Holdings, Inc. transactions in Zomedica Corp. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 16,693 shares of ZOM stock, worth $2,170. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,693
Previous 16,681 0.07%
Holding current value
$2,170
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.12 - $0.16 $1 - $1
12 Added 0.07%
16,693 $2,000
Q2 2024

Aug 13, 2024

SELL
$0.12 - $0.18 $5,190 - $7,785
-43,250 Reduced 72.17%
16,681 $2,000
Q1 2024

May 10, 2024

BUY
$0.12 - $0.19 $3,594 - $5,691
29,956 Added 99.94%
59,931 $8,000
Q4 2023

Feb 12, 2024

SELL
$0.15 - $0.22 $2,669 - $3,915
-17,798 Reduced 37.26%
29,975 $5,000
Q3 2023

Nov 13, 2023

BUY
$0.16 - $0.23 $2,184 - $3,140
13,655 Added 40.02%
47,773 $8,000
Q2 2023

Aug 10, 2023

BUY
$0.19 - $0.22 $136 - $157
716 Added 2.14%
34,118 $6,000
Q1 2023

May 12, 2023

SELL
$0.16 - $0.29 $448 - $812
-2,801 Reduced 7.74%
33,402 $7,000
Q4 2022

Feb 10, 2023

SELL
$0.16 - $0.25 $1,536 - $2,400
-9,601 Reduced 20.96%
36,203 $5,000
Q3 2022

Nov 14, 2022

SELL
$0.2 - $0.38 $1,849 - $3,513
-9,246 Reduced 16.8%
45,804 $10,000
Q2 2022

Aug 10, 2022

SELL
$0.2 - $0.34 $2,598 - $4,417
-12,994 Reduced 19.1%
55,050 $14,000
Q1 2022

May 04, 2022

SELL
$0.28 - $0.4 $2,119 - $3,027
-7,568 Reduced 10.01%
68,044 $22,000
Q3 2021

Nov 05, 2021

SELL
$0.46 - $0.81 $20,237 - $35,635
-43,994 Reduced 36.78%
75,612 $40,000
Q2 2021

Aug 02, 2021

SELL
$0.72 - $1.46 $1,539 - $3,121
-2,138 Reduced 1.76%
119,606 $101,000
Q1 2021

May 13, 2021

BUY
$0.35 - $2.7 $31,060 - $239,608
88,744 Added 268.92%
121,744 $193,000
Q4 2020

Feb 10, 2021

BUY
$0.07 - $0.25 $2,310 - $8,250
33,000 New
33,000 $7,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.